Allakos Inc. in brief
Allakos Inc. is an unlisted company in the Biotechnology industry, based in California, USA. It was founded in 2012. In the year to Dec 2020 it had sales of $0 M and a net loss of $153 M. It employs about 192 people.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Allakos Inc.
ALLAKOS is Biotechnology sector company with headquarters is in USA.They are developing therapeutic antibodies for inhibitory receptors on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases
Allakos Inc. timeline
- 2012
- 🏁· approximateFounded
- 2018
- 🔔· approximateInitial public offering on Nasdaq
Events of Allakos Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Allakos Inc.
- Acquisitions and changes
- No longer listed: ticker ALLK is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #771 (Jan 2020) · #752 (Jan 2021) · #3,021 (Jan 2022) · #2,353 (Dec 2022) · #2,796 (Jul 2023) · #3,118 (Jan 2024)
Annual results
- Revenue
- $0 M
- Operating income
- —
- Net income
- $-153 M
Dec-2020 ending year
Markets and events: Allakos Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-05-14 23:50 UTC, code D, resumed 04:00 UTC
- 2025-04-02 11:55 UTC, code T3, resumed 12:30 UTC
- 2025-01-27 11:55 UTC, code T3, resumed 12:30 UTC
Fails to deliver
- : 147 shares at $0.33
- : 31,674 shares at $0.33
- : 5 shares at $0.32
- : 337 shares at $0.32
- : 1,280 shares at $0.32
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
H-1B hiring at Allakos Inc.#
1 labor condition applications certified in fiscal 2025 for 1 positions, at a median wage of $104 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Data AnalystData Scientists | 1 | $104 K |
Where: San Jose, CA 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2025 | 1 | 1 | $104 K | 1 |
| FY2024 | 2 | 2 | $226 K | 2 |
| FY2023 | 3 | 3 | $199 K | 3 |
| FY2022 | 2 | 2 | $175 K | 2 |
| FY2021 | 3 | 3 | $190 K | 3 |
| FY2020 | 1 | 1 | $170 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Allakos Inc.
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 59 | · | · | · | · | · | · | · | · | · | · | · | 59 |
| 2022 | · | 61 | · | · | · | · | · | · | · | · | · | · | 61 |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| effective | 59 people | LayoffWARN notice | San Carlos, California | Notice list |
| effective | 61 people | LayoffWARN notice | Redwood City, California | Notice list |
Source: State WARN notices and SEC 8-K item 2.05
How Allakos Inc. compares in Biotechnology
- Revenue$0 M · higher than 0% of 647
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Allakos Inc.🇺🇸 | $239 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- Dec-2020 ending year
- Balance sheet:
- Dec-2020 ending year
- Employees:
- As on 2021
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Allakos Inc.? Verify and update this profile — free
Show Allakos Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.